Encompass Health (EHC) Stock Forecast & Price Target

Compare

388 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

EHC Analyst Ratings

Strong Buy

10 Buy

0 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Encompass

Health

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

EHC Stock 12 Month Forecast

Average Price Target

$130.50

▲(7.59%Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Encompass Health in the last 3 months. The average price target is $130.50 with a high forecast of $135.00 and a low forecast of $125.00. The average price target represents a 7.59% change from the last price of $121.29.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"71":"$71","136":"$136","87.25":"$87.3","103.5":"$103.5","119.75":"$119.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":135,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$135.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":130.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$130.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":125,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$125.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[71,87.25,103.5,119.75,136],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2024","6":"Aug<br/>2024","9":"Nov<br/>2024","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,115.94,117.40615384615384,118.87230769230769,120.33846153846153,121.80461538461539,123.27076923076923,124.73692307692308,126.20307692307692,127.66923076923077,129.13538461538462,130.60153846153847,132.0676923076923,133.53384615384616,{"y":135,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,115.94,117.06,118.17999999999999,119.3,120.42,121.53999999999999,122.66,123.78,124.9,126.02,127.14,128.26,129.38,{"y":130.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,115.94,116.63692307692307,117.33384615384615,118.03076923076922,118.72769230769231,119.42461538461538,120.12153846153846,120.81846153846153,121.51538461538462,122.21230769230769,122.90923076923077,123.60615384615384,124.30307692307693,{"y":125,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":72.35,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.54,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.65,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.3,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.78,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":84.91,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.53,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.56,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.4,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.56,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":99.1,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.28,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.94,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$135.00

Average Price Target$130.50

Lowest Price Target$125.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Matthew Gillmor CFAKeyBanc

KeyBanc

$122→$135

Buy

11.30%

Upside

Reiterated

05/27/25

KeyBanc Keeps Their Buy Rating on Encompass Health (EHC)

Joanna GajukBank of America Securities

Bank of America Securities

―

Buy

―

Reiterated

05/14/25

Bank of America Securities Sticks to Its Buy Rating for Encompass Health (EHC)

Whit MayoLeerink Partners

Leerink Partners

$120→$130

Buy

7.18%

Upside

Reiterated

04/30/25

Encompass Health price target raised to $130 from $120 at LeerinkEncompass Health price target raised to $130 from $120 at Leerink

David S MacdonaldTruist Financial

Truist Financial

$116→$135

Buy

11.30%

Upside

Reiterated

04/28/25

Analysts Offer Insights on Healthcare Companies: Encompass Health (NYSE: EHC), Autolus Therapeutics (NASDAQ: AUTL) and PROCEPT BioRobotics (NASDAQ: PRCT)

Ann HynesMizuho Securities

Mizuho Securities

$110→$130

Buy

7.18%

Upside

Reiterated

04/28/25

Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals Ltd. (Other OTC: TLPPF), Encompass Health (NYSE: EHC) and Revolution Medicines (NASDAQ: RVMD)

A.J. RiceUBS

UBS

$117→$130

Buy

7.18%

Upside

Reiterated

04/28/25

Encompass Health price target raised to $130 from $117 at UBSEncompass Health price target raised to $130 from $117 at UBS

John RansomRaymond James

Raymond James

$120→$130

Buy

7.18%

Upside

Reiterated

04/28/25

Analysts' Top Healthcare Picks: Encompass Health (EHC), Evaxion Biotech (EVAX)

Ryan DanielsWilliam Blair

William Blair

―

Buy

―

Reiterated

04/28/25

Encompass Health: Strong Performance and Strategic Expansion Drive Buy Rating

Ben HendrixRBC Capital

RBC Capital

$110→$125

Buy

3.06%

Upside

Reiterated

04/27/25

RBC Capital Reaffirms Their Buy Rating on Encompass Health (EHC)

Andrew Mok CFABarclays

Barclays

$118→$129

Buy

6.36%

Upside

Reiterated

04/25/25

Analysts Offer Insights on Healthcare Companies: Boston Scientific (NYSE: BSX), Encompass Health (NYSE: EHC) and Integer Holdings (NYSE: ITGR)

Brian TanquilutJefferies

Jefferies

$115

Buy

-5.19%

Downside

Reiterated

02/07/25

We are bullish on EHC and rank it as one of our top picks given our belief that the stock has further room to run given 1) mgmt's typical guidance conservatism that likely translates to EBITDA upside surprises over the course of FY25, 2) our expectation for multiple expansion (>2 turns) as EHC continues to execute and demonstrate its ability to consistently deliver +LDD EBITDA growth, and 3) fund rotation into a name viewed as defensive vs NT political risk.

Pito ChickeringDeutsche Bank

Deutsche Bank

$95

Buy

-21.68%

Downside

Reiterated

08/07/24

Encompass Health's Q2 Resilience and Optimistic Outlook Support Buy Rating

Scott FidelStephens

Stephens

$98→$105

Buy

-13.43%

Downside

Reiterated

07/24/24

Encompass Health Corp (EHC) PT Raised to $105 at StephensStephens analyst Scott Fidel raised the price target on Encompass Health Corp (NYSE: EHC) to $105.00 (from $98.00) while maintaining a Overweight rating.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Matthew Gillmor CFAKeyBanc

KeyBanc

$122→$135

Buy

11.30%

Upside

Reiterated

05/27/25

KeyBanc Keeps Their Buy Rating on Encompass Health (EHC)

Joanna GajukBank of America Securities

Bank of America Securities

―

Buy

―

Reiterated

05/14/25

Bank of America Securities Sticks to Its Buy Rating for Encompass Health (EHC)

Whit MayoLeerink Partners

Leerink Partners

$120→$130

Buy

7.18%

Upside

Reiterated

04/30/25

Encompass Health price target raised to $130 from $120 at LeerinkEncompass Health price target raised to $130 from $120 at Leerink

David S MacdonaldTruist Financial

Truist Financial

$116→$135

Buy

11.30%

Upside

Reiterated

04/28/25

Analysts Offer Insights on Healthcare Companies: Encompass Health (NYSE: EHC), Autolus Therapeutics (NASDAQ: AUTL) and PROCEPT BioRobotics (NASDAQ: PRCT)

Ann HynesMizuho Securities

Mizuho Securities

$110→$130

Buy

7.18%

Upside

Reiterated

04/28/25

Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals Ltd. (Other OTC: TLPPF), Encompass Health (NYSE: EHC) and Revolution Medicines (NASDAQ: RVMD)

A.J. RiceUBS

UBS

$117→$130

Buy

7.18%

Upside

Reiterated

04/28/25

Encompass Health price target raised to $130 from $117 at UBSEncompass Health price target raised to $130 from $117 at UBS

John RansomRaymond James

Raymond James

$120→$130

Buy

7.18%

Upside

Reiterated

04/28/25

Analysts' Top Healthcare Picks: Encompass Health (EHC), Evaxion Biotech (EVAX)

Ryan DanielsWilliam Blair

William Blair

―

Buy

―

Reiterated

04/28/25

Encompass Health: Strong Performance and Strategic Expansion Drive Buy Rating

Ben HendrixRBC Capital

RBC Capital

$110→$125

Buy

3.06%

Upside

Reiterated

04/27/25

RBC Capital Reaffirms Their Buy Rating on Encompass Health (EHC)

Andrew Mok CFABarclays

Barclays

$118→$129

Buy

6.36%

Upside

Reiterated

04/25/25

Analysts Offer Insights on Healthcare Companies: Boston Scientific (NYSE: BSX), Encompass Health (NYSE: EHC) and Integer Holdings (NYSE: ITGR)

Brian TanquilutJefferies

Jefferies

$115

Buy

-5.19%

Downside

Reiterated

02/07/25

Pito ChickeringDeutsche Bank

Deutsche Bank

$95

Buy

-21.68%

Downside

Reiterated

08/07/24

Encompass Health's Q2 Resilience and Optimistic Outlook Support Buy Rating

Scott FidelStephens

Stephens

$98→$105

Buy

-13.43%

Downside

Reiterated

07/24/24

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Encompass Health

1 Month

xxx

Success Rate

12/16 ratings generated profit

Average Return

+3.54%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 75.00% of your transactions generating a profit, with an average return of +3.54% per trade.

3 Months

xxx

Success Rate

25/31 ratings generated profit

Average Return

+6.82%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 80.65% of your transactions generating a profit, with an average return of +6.82% per trade.

1 Year

David S MacdonaldTruist Financial

Success Rate

30/32 ratings generated profit

Average Return

+29.12%

reiterated a buy rating last month

Copying David S Macdonald's trades and holding each position for 1 Year would result in 93.75% of your transactions generating a profit, with an average return of +29.12% per trade.

2 Years

xxx

Success Rate

30/32 ratings generated profit

Average Return

+53.61%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 93.75% of your transactions generating a profit, with an average return of +53.61% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

EHC Analyst Recommendation Trends

Rating

Oct 24

Nov 24

Feb 25

Apr 25

May 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, EHC has received 27 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. EHC average Analyst price target in the past 3 months is 130.50.

Each month's total comprises the sum of three months' worth of ratings.

EHC Financial Forecast

EHC Earnings Forecast

Next quarter’s earnings estimate for EHC is $1.21 with a range of $1.14 to $1.31. The previous quarter’s EPS was $1.37. EHC beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year EHC has Outperformed its overall industry.

EHC Sales Forecast

Next quarter’s sales forecast for EHC is $1.43B with a range of $1.42B to $1.45B. The previous quarter’s sales results were $1.46B. EHC beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year EHC has Outperformed its overall industry.

EHC Stock Forecast FAQ

What is EHC’s average 12-month price target, according to analysts?

Based on analyst ratings, Encompass Health’s 12-month average price target is 130.50.

What is EHC’s upside potential, based on the analysts’ average price target?

Encompass Health has 7.59% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is EHC a Buy, Sell or Hold?

Encompass Health has a consensus rating of Strong Buy which is based on 10 buy ratings, 0 hold ratings and 0 sell ratings.

What is Encompass Health’s price target?

The average price target for Encompass Health is 130.50. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $135.00 ,the lowest forecast is $125.00. The average price target represents 7.59% Increase from the current price of $121.29.

What do analysts say about Encompass Health?

Encompass Health’s analyst rating consensus is a Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of EHC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Encompass Health (EHC) Stock Forecast & Price Target

EHC Analyst Ratings

EHC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Encompass Health

EHC Analyst Recommendation Trends

EHC Financial Forecast

EHC Earnings Forecast

EHC Sales Forecast

EHC Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts